Aberrant tumor vasculature and angiogenesis: new opportunities for cancer therapy.
Zhu
Zhenping
Z
Department of Antibody Technology, ImClone Systems, 180 Varick Street, New York, NY 10014, USA.
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D006801:Humans; D009369:Neoplasms / Q000098:blood supply* / Q000188:drug therapy* / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D012039:Regional Blood Flow / Q000187:drug effects
D020533:Angiogenesis Inhibitors